OUTCOME OF EYES TREATED FOR RETINOPATHY OF PREMATURITY IN POSTERIOR ZONE I An Eastern India Study

被引:0
|
作者
Padhi, Tapas R. [1 ]
Bhunia, Souvik [1 ]
Shah, Miloni [1 ]
Sahu, Suman [1 ]
Das, Taraprasad [2 ]
Bhusal, Utpal [1 ]
Singh, Aveenash [1 ]
Samantaray, Balakrushna [3 ]
Patro, Krishna [3 ]
Devi, Sabita [4 ]
Routray, Dipanweeta [5 ]
Mohamed, Ashik [1 ]
Pradhan, Lingaraj [6 ]
Jalali, Subhadra [2 ]
机构
[1] Anant Bajaj Retina Inst, L V Prasad Eye Inst, Mithu Tulsi Chanrai Campus, Bhubaneswar, India
[2] L V Prasad Eye Inst, Anant Bajaj Retina Inst, Kallam Anji Reddy Campus, Hyderabad, India
[3] SCB Med Coll, Dept Ophthalmol, Cuttack, India
[4] MKCG Med Coll, Dept Ophthalmol, Berhampur, India
[5] Dharanidhar Med Coll Hosp, Dept Community Med, Keonjhar, India
[6] Capital Hosp, Dept Paediat, Bhubaneswar, India
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2024年 / 44卷 / 06期
关键词
posterior Zone I retinopathy of prematurity (ROP); posterior ROP; outcome; posterior Zone I ROP; INTERNATIONAL CLASSIFICATION; INTRAVITREAL BEVACIZUMAB; LASER; MANAGEMENT; ROP;
D O I
10.1097/IAE.0000000000004067
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To analyze the outcomes of eyes treated for retinopathy of prematurity in posterior Zone I. Methods: In a part retrospective (9 years) and part prospective (1 year) interventional study, we analyzed eyes treated for retinopathy of prematurity in posterior Zone I with a minimum follow-up for 6 months. Results: This study included 109 eyes of 56 infants; mean gestational age and birth weights were 29.3 (+/- 2.1) weeks and 1112.5 (+/- 381.9) g, respectively. The treatment included intravitreal anti-vascular endothelial growth factor as the initial treatment modality in 101 eyes (92.6%), either alone (27 eyes) or combined with laser or vitreous surgery (73 eyes). Laser was the initial treatment modality in eight eyes, either alone (n = 3) or in combination with surgery (n = 5). With anti-vascular endothelial growth factor alone, 30.68% (n = 27) eyes responded favorably, and the remaining 69.32% (n = 59) eyes needed retreatment (laser in the majority). At the final follow-up, 89.9% (out of 109) of eyes did well anatomically. Good outcome was significantly linked to no detachment at presentation (P < 0.0001) and the presence of well-defined central vascular trunks (P = 0.001). Conclusion: Treating the eyes before retinal detachment with bevacizumab followed by laser (and surgery, if needed) results in a favorable outcome in babies with posterior Zone I retinopathy of prematurity.
引用
收藏
页码:1073 / 1082
页数:10
相关论文
共 50 条
  • [21] Outcome of Eyes Developing Retinal Detachment During the Early Treatment for Retinopathy of Prematurity Study
    Repka, Michael X.
    Tung, Betty
    Good, William V.
    Capone, Antonio, Jr.
    Shapiro, Michael J.
    ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (09) : 1175 - 1179
  • [22] Refractive outcome in eyes with retinopathy of prematurity treated with cryotherapy or diode laser: 3 year follow up
    KnightNanan, DM
    OKeefe, M
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1996, 80 (11) : 998 - 1001
  • [23] Outcome of cataract surgery in patients treated for retinopathy of prematurity
    Nguyen, Huy D.
    Yen, Kimberly G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [24] Progression and timing of treatment of zone I retinopathy of prematurity
    Soh, Yuka
    Fujino, Takahiro
    Hatsukawa, Yoshikazu
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 146 (03) : 369 - 374
  • [25] Clinical profile and management outcomes of posterior zone 1 retinopathy of prematurity
    Sachan, Anusha
    Chandra, Parijat
    Chandra Lakshmi, C.
    Chawla, Rohan
    Shah, Pooja Rajesh
    Kumar, Atul
    INTERNATIONAL OPHTHALMOLOGY, 2022, 42 (11) : 3303 - 3309
  • [26] Clinical profile and management outcomes of posterior zone 1 retinopathy of prematurity
    Anusha Sachan
    Parijat Chandra
    C. Chandra Lakshmi
    Rohan Chawla
    Pooja Rajesh Shah
    Atul Kumar
    International Ophthalmology, 2022, 42 : 3303 - 3309
  • [27] Supplemental Laser for Eyes Treated with Bevacizumab Monotherapy in Severe Retinopathy of Prematurity
    Tandon, Manish
    Vishal, M. Y.
    Kohli, Piyush
    Rajan, Renu P.
    Ramasamy, Kim
    OPHTHALMOLOGY RETINA, 2018, 2 (06): : 623 - 628
  • [28] Outcome of real-time telescreening for retinopathy of prematurity using videoconferencing in a community setting in Eastern India
    Padhi, Tapas R.
    Bhunia, Souvik
    Das, Taraprasad
    Nayak, Sameer
    Jalan, Manav
    Rath, Suryasnata
    Barik, Biswajeet
    Ali, Hasnat
    Rani, Padmaja Kumari
    Routray, Dipanwita
    Jalali, Subhadra
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (05) : 697 - 703
  • [29] Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
    Islam, Yasmin
    Andersen, Lorick
    Agarwal-Sinha, Swati
    OPHTHALMIC RESEARCH, 2022, 65 (02) : 229 - 236
  • [30] Treatment outcome in fellow eyes after laser photocoagulation for retinopathy of prematurity
    Brooks, SE
    Johnson, M
    Wallace, DK
    Paysse, EA
    Coats, DK
    Marcus, DM
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 127 (01) : 56 - 61